A novel VEGFR inhibitor ZLF-095 with potent antitumor activity and low toxicity
Angiogenesis plays a critical role in the survival, progression and metastasis of malignant tumors. Multiple factors are known to induce tumor angiogenesis, vascular endothelial growth factor (VEGF) is the most important one. Lenvatinib is an oral multi-kinase inhibitor of VEGFRs which has been appr...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2023-05-01
|
| סדרה: | Heliyon |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2405844023023599 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
